Literature DB >> 9659263

Evaluation of the efficacy of 99mTc-Infecton, a novel agent for detecting sites of infection.

A V Hall1, K K Solanki, S Vinjamuri, K E Britton, S S Das.   

Abstract

AIMS: To determine the sensitivity and specificity of 99mTc-Infecton (Infecton), a novel ciprofloxacin based imaging agent, in detecting sites of infection.
METHODS: Ninety patients thought to be suffering from a variety of infections were administered 300-400 MBq of Infecton intravenously. Whole body images were taken one and four hours later. Appropriate specimens were taken for microbiological investigations. Statistical analysis was performed using a computer statistical package.
RESULTS: Ninety eight Infecton images were produced. Forty one of these were positive, including three false positives, where the patients had non-infective conditions. Fifty seven negative images were obtained, of which 41 were true negatives and 16 were false negatives, having definite evidence of infection. Thus, Infecton imaging has a sensitivity of 70.3% and a specificity of 93.1% for detecting infective foci. The positive and negative predictive values were 92.6% and 71.9%, respectively.
CONCLUSION: Infecton imaging is a new diagnostic tool that is specific for detecting sites of bacterial infection in the body. The high positive predictive value displayed by the technique is clinically important because a positive image strongly supports a diagnosis of bacterial infection. A negative result does not rule out an infection, and may be a result of previous or current antibiotic treatment and/or infection with organisms that do not take up Infecton. Infecton imaging has major advantages over well established imaging techniques, including radiolabelled leucocytes, and may prove to be a superior method for localising bacterial infections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9659263      PMCID: PMC500642          DOI: 10.1136/jcp.51.3.215

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  Localization of Fc and Fab fragments of nonspecific polyclonal IgG at focal sites of inflammation.

Authors:  A J Fischman; R H Rubin; J A White; E Locke; R A Wilkinson; M Nedelman; R J Callahan; B A Khaw; H W Strauss
Journal:  J Nucl Med       Date:  1990-07       Impact factor: 10.057

2.  99Tcm-labelled HSA-nanocolloid versus 111In oxine-labelled granulocytes in detecting skeletal septic process.

Authors:  K Streule; M de Schrijver; R Fridrich
Journal:  Nucl Med Commun       Date:  1988-01       Impact factor: 1.690

3.  Comparison of 99mTc infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection.

Authors:  S Vinjamuri; A V Hall; K K Solanki; J Bomanji; Q Siraj; E O'Shaughnessy; S S Das; K E Britton
Journal:  Lancet       Date:  1996-01-27       Impact factor: 79.321

4.  CDC definitions for nosocomial infections, 1988.

Authors:  J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal:  Am J Infect Control       Date:  1988-06       Impact factor: 2.918

5.  Technetium-labelled liposome imaging for deep-seated infection.

Authors:  J R Morgan; L A Williams; C B Howard
Journal:  Br J Radiol       Date:  1985-01       Impact factor: 3.039

6.  Effect of ciprofloxacin on intracellular organisms: in-vitro and in-vivo studies.

Authors:  C S Easmon; J P Crane; A Blowers
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

7.  Indium-111-labeled leukocytes for the detection of infection: current status.

Authors:  F L Datz
Journal:  Semin Nucl Med       Date:  1994-04       Impact factor: 4.446

  7 in total
  26 in total

1.  Concerns about 99mTc-labelled ciprofloxacin for infection detection.

Authors:  K E Britton; D W Wareham; S S Das
Journal:  Eur J Nucl Med       Date:  2001-06

2.  Imaging bacterial infection with (99m)Tc-ciprofloxacin (Infecton).

Authors:  K E Britton; D W Wareham; S S Das; K K Solanki; H Amaral; A Bhatnagar; A H S Katamihardja; J Malamitsi; H M Moustafa; V E Soroa; F X Sundram; A K Padhy
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

Review 3.  Radionuclide imaging of spinal infections.

Authors:  Filip Gemmel; Nicolas Dumarey; Christopher J Palestro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-10       Impact factor: 9.236

4.  Concerns about (99m)Tc-labelled ciprofloxacin for infection detection.

Authors:  E K Pauwels; M M Welling; A Lupetti; A Paulusma-Annema; P H Nibbering; H S Balter
Journal:  Eur J Nucl Med       Date:  2000-12

5.  99mTc-zolmitriptan: radiolabeling, molecular modeling, biodistribution and gamma scintigraphy as a hopeful radiopharmaceutical for lung nuclear imaging.

Authors:  H M Rashed; F A Marzook; H Farag
Journal:  Radiol Med       Date:  2016-09-01       Impact factor: 3.469

6.  Evaluation of adequacy of short-course chemotherapy for extraspinal osteoarticular tuberculosis using 99mTc ciprofloxacin scan.

Authors:  Vikas Bhardwaj; Mayank Agrawal; Tarun Suri; Sumit Sural; Ravi Kashyap; Anil Dhal
Journal:  Int Orthop       Date:  2010-11-30       Impact factor: 3.075

Review 7.  Ciprofloxacin: from infection therapy to molecular imaging.

Authors:  Syed Ali Raza Naqvi; Samina Roohi; Anam Iqbal; Tauqir A Sherazi; Ameer Fawad Zahoor; Muhammad Imran
Journal:  Mol Biol Rep       Date:  2018-07-04       Impact factor: 2.316

8.  Radiolabeling, biodistribution and gamma scintigraphy of noscapine hydrochloride in normal and polycystic ovary induced rats.

Authors:  Anjali Priyadarshani; Krishna Chuttani; Gaurav Mittal; Aseem Bhatnagar
Journal:  J Ovarian Res       Date:  2010-04-27       Impact factor: 4.234

9.  Sternal osteomyelitis caused by Aspergillus fumigatus in a patient with previously treated Hodgkin's disease.

Authors:  D Allen; S Ng; K Beaton; D Taussig
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

10.  Tc-99m Ciprofloxacin SPECT of Pulmonary Tuberculosis.

Authors:  Minkyung Lee; Minki Yoon; Kyung Hoon Hwang; Wonsick Choe
Journal:  Nucl Med Mol Imaging       Date:  2010-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.